SLC6A4 and Glucose intolerance: Our findings provide direct in vivo evidence for the involvement of estrogen suppression in SERT deficiency-induced obesity and glucose intolerance and suggest therapeutic implications for SERT deficiency-associated metabolic abnormalities.